GSADX | NRGEX | GSADX / NRGEX | |
Total Expense Ratio | 0.91 | 0.03 | 3,033% |
Annual Report Gross Expense Ratio | 1.29 | 0.69 | 187% |
Fund Existence | 6 years | 4 years | - |
Gain YTD | 4.188 | -2.076 | -202% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 354M | 9.11B | 4% |
Annual Yield % from dividends | 0.00 | 0.54 | - |
Returns for 1 year | 12.60 | -2.66 | -474% |
Returns for 3 years | 31.25 | -2.78 | -1,123% |
Returns for 5 years | 29.01 | N/A | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BMED | 25.64 | 0.52 | +2.07% |
iShares Health Innovation Active ETF | |||
IGHG | 78.78 | 0.07 | +0.09% |
ProShares Investment Grade—Intr Rt Hdgd | |||
LGDX | 21.88 | N/A | N/A |
Intech S&P Large Cap Diversified Alpha ETF | |||
ILCB | 89.44 | N/A | N/A |
iShares Morningstar U.S. Equity ETF | |||
JMM | 6.31 | -0.04 | -0.63% |
NUVEEN MULTI-MARKET Income FUND |